Biochemistry, Genetics and Molecular Biology
Next Generation Sequencing
100%
Genetics
69%
Exome Sequencing
64%
Genomics
49%
Platelet Reactivity
44%
Clopidogrel
44%
Pharmacogenetic Testing
39%
Allele
39%
Human Papillomavirus Type 16
33%
Transcription Factor
33%
Gene Frequency
31%
Reporter Gene
30%
Luciferase
30%
BRCA1
28%
Genetic Determinism
27%
Germline
25%
Germ Cell
25%
Genetic Risk
25%
Genetic Divergence
23%
T Cell
22%
Electrophoretic Mobility Shift Assay
22%
Binding Site
22%
MicroRNA
20%
Missense
19%
Gene Expression
19%
SARS Coronavirus
17%
BRCA2
16%
Rare Variant
16%
Pharmacogenomics
15%
Methylation
15%
Case-Control Study
14%
Single-Nucleotide Polymorphism
14%
Metabolic Pathway
14%
Genetic Variation
14%
Cancer Cell
13%
Decitabine
13%
Genotyping
13%
Promoter Region
13%
Pharmacogenetic Variant
13%
Dideoxynucleotide Sequencing
13%
Bioinformatics
12%
Population Genetics
12%
Gene Control
11%
TCF3
11%
Missense Mutation
11%
Lymphoid Enhancer-Binding Factor 1
11%
Cancer Immunotherapy
11%
Artificial Intelligence
11%
CpG Site
11%
Melting Point
11%
Keyphrases
Next-generation Sequencing
82%
Colombians
72%
Platelet Reactivity
44%
Whole Exome Sequencing
37%
COVID-19
35%
Clopidogrel
35%
Colorectal Cancer
34%
Breast Cancer
33%
High On-treatment Platelet Reactivity
33%
Pharmacological Analysis
33%
Mayors
31%
Preeclampsia
30%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
28%
Pathogenic Variants
28%
Genetic Profile
26%
HPV16
25%
High-risk Human Papillomavirus (HR-HPV)
24%
Colombia
23%
MicroRNA
22%
Functional Analysis
22%
HELLP Syndrome
22%
HPV16 E7
22%
New Risks
22%
Polymorphism
22%
Genetic Risk
20%
Allele Frequency
20%
Breast Cancer Susceptibility Gene 1 (BRCA1)
19%
Adverse Drug Reaction
19%
Colombian Patients
19%
Rare Variants
18%
Closure Time
18%
Single nucleotide Polymorphism
18%
Inter-individual Variability
18%
Molecular Variants
17%
Functional Impact
17%
Pharmacogenomics
17%
Non-genetic Factors
16%
Genetic Variants
16%
Functional Validation
15%
Cervical Cancer
15%
Human Papillomavirus Testing
14%
Clinical Practice
14%
5-aza-2′-deoxycytidine
14%
Genotype
14%
Methylation
14%
Molecular Diagnostics
14%
Etiology
14%
STOX1
14%
Pharmacogenetic Variants
13%
TFL1
12%
